eGenesis, Inc. — Form D

eGenesis, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-14. The offering totals $100.0M, of which $100.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
Juergen L EckhardtDirectorCAMBRIDGE, MA
Lucio L IannoneDirectorCAMBRIDGE, MA
Bob MoreDirectorVenice, CA
Albert L WiegmanDirectorCAMBRIDGE, MA
Kenneth FanExecutive OfficerDover, DE
Ariel JasieExecutive OfficerCAMBRIDGE, MA
Steven GillisDirectorSouth San Francisco, CA
Boris NikolicDirectorAtlanta, GA
Geoff MacKayExecutive OfficerToronto, A6
Lucio IannoneDirectorWatertown, MA
Sapna SrivastavaExecutive OfficerBethesda, MD
Sarah SchlesingerDirectorCAMBRIDGE, MA
Mark PruzanskiDirectorCAMBRIDGE, MA
Brad SmithDirectorCAMBRIDGE, MA
Rahul KakkarDirectorCAMBRIDGE, MA
Albert WiegmanDirectorCAMBRIDGE, MA
Julie SunderlandDirectorCAMBRIDGE, MA
Michael CurtisDirectorCAMBRIDGE, MA
Michael CurtisExecutive OfficerCAMBRIDGE, MA
Jennifer BergheiserExecutive OfficerCAMBRIDGE, MA
Paul SekhriDirectorNew York, NY
Paul SekhriExecutive OfficerNew York, NY
Kathleen FanningDirectorCAMBRIDGE, MA
Peter HansonExecutive OfficerCAMBRIDGE, MA
Isaac CiechanoverDirectorCAMBRIDGE, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2024-02-27D$28.7M$25.4M
2021-03-10D$125.0M$125.0M
2017-03-23D$38.2M$12.6M
2016-08-23D$3.0M$2.0M

More